These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29735752)

  • 1. Selection of Priority Natural Products for Evaluation as Potential Precipitants of Natural Product-Drug Interactions: A NaPDI Center Recommended Approach.
    Johnson EJ; González-Peréz V; Tian DD; Lin YS; Unadkat JD; Rettie AE; Shen DD; McCune JS; Paine MF
    Drug Metab Dispos; 2018 Jul; 46(7):1046-1052. PubMed ID: 29735752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommended Approaches for Pharmacokinetic Natural Product-Drug Interaction Research: a NaPDI Center Commentary.
    Paine MF; Shen DD; McCune JS
    Drug Metab Dispos; 2018 Jul; 46(7):1041-1045. PubMed ID: 29735755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Data Repository for Pharmacokinetic Natural Product-Drug Interactions: From Chemical Characterization to Clinical Studies.
    Birer-Williams C; Gufford BT; Chou E; Alilio M; VanAlstine S; Morley RE; McCune JS; Paine MF; Boyce RD
    Drug Metab Dispos; 2020 Oct; 48(10):1104-1112. PubMed ID: 32601103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Pharmacokinetic Natural Product-Drug Interactions for Decision-Making: A NaPDI Center Recommended Approach.
    Cox EJ; Tian DD; Clarke JD; Rettie AE; Unadkat JD; Thummel KE; McCune JS; Paine MF
    Pharmacol Rev; 2021 Apr; 73(2):847-859. PubMed ID: 33712517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adapting regulatory drug-drug interaction guidance to design clinical pharmacokinetic natural product-drug interaction studies: A NaPDI Center recommended approach.
    Cox EJ; Rettie AE; Unadkat JD; Thummel KE; McCune JS; Paine MF
    Clin Transl Sci; 2022 Feb; 15(2):322-329. PubMed ID: 34699676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extending the DIDEO ontology to include entities from the natural product drug interaction domain of discourse.
    Judkins J; Tay-Sontheimer J; Boyce RD; Brochhausen M
    J Biomed Semantics; 2018 May; 9(1):15. PubMed ID: 29743102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a Knowledge Graph for Pharmacokinetic Natural Product-Drug Interactions.
    Taneja SB; Callahan TJ; Paine MF; Kane-Gill SL; Kilicoglu H; Joachimiak MP; Boyce RD
    J Biomed Inform; 2023 Apr; 140():104341. PubMed ID: 36933632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Products: Experimental Approaches to Elucidate Disposition Mechanisms and Predict Pharmacokinetic Drug Interactions.
    Paine MF
    Drug Metab Dispos; 2020 Oct; 48(10):956-962. PubMed ID: 32816868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: metabolism and drug-drug interaction potential of biotherapeutics.
    Li AP
    Curr Drug Metab; 2012 Sep; 13(7):881. PubMed ID: 22475272
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential interactions between complementary/alternative products and conventional medicines in a Medicare population.
    Elmer GW; Lafferty WE; Tyree PT; Lind BK
    Ann Pharmacother; 2007 Oct; 41(10):1617-24. PubMed ID: 17785609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural product-likeness score and its application for prioritization of compound libraries.
    Ertl P; Roggo S; Schuffenhauer A
    J Chem Inf Model; 2008 Jan; 48(1):68-74. PubMed ID: 18034468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prioritizing pharmacokinetic drug interaction precipitants in natural products: application to OATP inhibitors in grapefruit juice.
    Johnson EJ; Won CS; Köck K; Paine MF
    Biopharm Drug Dispos; 2017 Apr; 38(3):251-259. PubMed ID: 28032362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing a drug-like natural product library.
    Quinn RJ; Carroll AR; Pham NB; Baron P; Palframan ME; Suraweera L; Pierens GK; Muresan S
    J Nat Prod; 2008 Mar; 71(3):464-8. PubMed ID: 18257534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal Drug Interactions Mediated by OATPs: A Systematic Review of Preclinical and Clinical Findings.
    Yu J; Zhou Z; Tay-Sontheimer J; Levy RH; Ragueneau-Majlessi I
    J Pharm Sci; 2017 Sep; 106(9):2312-2325. PubMed ID: 28414144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Advanced Technologies in Natural Product Research: A Review with Special Emphasis on ADMET Profiling.
    Borah P; Hazarika S; Deka S; Venugopala KN; Nair AB; Attimarad M; Sreeharsha N; Mailavaram RP
    Curr Drug Metab; 2020; 21(10):751-767. PubMed ID: 32664837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural product and natural product derived drugs in clinical trials.
    Butler MS; Robertson AA; Cooper MA
    Nat Prod Rep; 2014 Nov; 31(11):1612-61. PubMed ID: 25204227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems pharmacology strategies for anticancer drug discovery based on natural products.
    Luo F; Gu J; Chen L; Xu X
    Mol Biosyst; 2014 Jul; 10(7):1912-7. PubMed ID: 24802653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of physiologically based pharmacokinetic modeling and simulation in drug development.
    Shardlow CE; Generaux GT; Patel AH; Tai G; Tran T; Bloomer JC
    Drug Metab Dispos; 2013 Dec; 41(12):1994-2003. PubMed ID: 24009310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the efficiency of mixed effects modelling in quantifying metabolism based drug-drug interactions: using in vitro data as an aid to assess study power.
    Johnson TN; Kerbusch T; Jones B; Tucker GT; Rostami-Hodjegan A; Milligan PA
    Pharm Stat; 2009; 8(3):186-202. PubMed ID: 19291743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug metabolites as cytochrome p450 inhibitors: a retrospective analysis and proposed algorithm for evaluation of the pharmacokinetic interaction potential of metabolites in drug discovery and development.
    Callegari E; Kalgutkar AS; Leung L; Obach RS; Plowchalk DR; Tse S
    Drug Metab Dispos; 2013 Dec; 41(12):2047-55. PubMed ID: 23792812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.